411 REFERENCE · Wikibooks
Radiation Oncology/Sarcoma/Fibrosarcoma
Reference material by Wikibooks contributors. This retains its source identity and is not 411 news reporting.
Fibrosarcoma
Benign Fibrous Histologies
Nodular fasciitis: rapid growth over several weeks, pain, tenderness. Plump mature fibroblasts. Self-limiting process; recurrence uncommon after excision
Fibroma: nonspecific term. Dense fibrous nodule. Simple excision
Elastofibroma: rare, slow-growing benign tumor. Typically lower portion of the scapula. Repetitive manual tasks. Considered reactive lesions. Swollen eosinophilic collagen and elastic fibers. Simple excision
Superficial fibromatosis: arise from fascia or aponeuroses, small and slow growing
Palmar fibromatosis (Dupuytren's contracture) most common
Penile fibromatosis (Peyronie's disease) relatively rare, though more common in men who have palmar fibromatosis
Deep fibromatosis: clinically diverse, deep-seated fibrous neoplasms
For more detail, please see the Desmoid tumor page
Fibrosarcoma Epidemiology
2-6% of primary malignant bone lesions
Arise most commonly in tubular long bones, usually femur or tibia
Most patients are 30-70; equal men and women
Predisposing factors (~30% cases) include Paget's, fibrous dysplasia, osteomyelitis, bone infarcts, bone cysts, benign giant cell tumors, desmoplastic fibromas, or previous RT treatment
Natural History
Locally aggressive
Metastatic potential related to grade
High grade similar to osteosarcoma: 5-year OS ~25%
Low grade: 5-year (and 10-year) OS ~50%. Mets rate 5-15%
Survival: 5-year 34%, 10-year 28%, 20-year 25%
Children have relatively milder prognosis
Diagnosis
Lytic with no reactive sclerosis
High grade lesions show cortical destruction and periosteal reaction; sometimes with soft-tissue mass
Radiographically very similar to osteosarcoma
Staging
Please see the bone staging page
Treatment Overview
Aggressive surgical resection
Not considered highly radiosensitive, but RT recommended for inoperable tumors, residual disease, and palliation
Perez (4th ed) recommends doses 66-70Gy with shrinking-field technique